Predicting Exacerbations in Alpha-1 Antitrypsin Deficiency Using Clinical and Pulmonary Function Tests: Portuguese EARCO Registry.

Nuno FariaJoana GomesCatarina GuimarãesRaquel MarçôaBeatriz FerrazMaria Sucena

Published in: Respiration; international review of thoracic diseases (2024)

DLCO, BODE, and BODEx were independent predictors of exacerbations at 12 months in AATD patients. Understanding these risk factors can aid decision-making on AATD-related lung disease management and improve patient outcomes.

Keyphrases

chronic obstructive pulmonary disease
risk factors
decision making
cystic fibrosis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
patient reported outcomes
drug induced